Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
Analysis of revenue contributions from different manufacturers in the market.
Aminoglycosides Market Definition
The aminoglycosides market deals in the manufacturing and distribution of gram-negative antibacterial therapeutics worldwide. Various products manufactured by this industry mainly consist of neomycin, tobramycin, gentamicin, amikacin, paromomycin, streptomycin, kanamycin, and others. A well-established supply chain of hospital pharmacies, online pharmacies, retail pharmacies, and others distributes these therapeutics. The end-users of this industry comprise hospitals, homes, specialty clinics, and others.
The growing application of these therapeutics in the veterinary sector due to their ability to treat several animal bacterial diseases has boosted the market growth. Also, the increased use of aminoglycosides for treating skin infections and pelvic diseases in humans is positively shaping the market. Moreover, the rising application of these therapies in the treatment of respiratory diseases, along with the increased demand for aminoglycosides-based injectables and oral medications, is expected to drive the growth of the aminoglycosides market.
In February 2024, Cipla Limited announced that the Central Drugs Standard Control Organization (CDSCO) regarding the commercialization of plazomicin. Plazomicin is an effective medicine for complicated urinary tract infections such as pyelonephritis. The development associated with synthesizing novel aminoglycoside derivatives and multidrug-resistant antibiotics is expected to create ample growth opportunities for the market players in the upcoming days.
Download
Actionable Solutions
